Dexcom AI Adoption Tracker
Last updated: August 9, 2026
Overview
Dexcom, the global leader in glucose biosensing technology, has positioned itself at the forefront of AI-driven diabetes care innovation[1]. In December 2024, the company launched the first generative AI platform in glucose biosensing, integrated into its over-the-counter Stelo CGM system[2]. This GenAI platform, built on Google Cloud's Vertex AI and Gemini models, analyzes individual health data patterns to provide personalized insights on how lifestyle choices impact glucose levels[2]. With Jake Leach assuming the CEO role in January 2026, Dexcom is focusing on transforming from a medical device company to a comprehensive metabolic health platform, targeting not only diabetes patients but also prediabetics and wellness-focused consumers[3].
AI Maturity Index
Radar Comparison
Peer Comparison: Dexcom vs healthcare
Based on 66 companies in sector
| Dimension | Dexcom | Sector Avg | Diff |
|---|---|---|---|
| Adoption | 4.0 | 3.7 | +0.3 |
| Proficiency | 4.0 | 3.5 | +0.5 |
| Impact | 3.0 | 3.6 | -0.6 |
| Overall | 3.6 | 3.6 | 0.0 |
AI Hiring Signals
Dexcom Job Postings Analysis
Tech vs Non-Tech AI Requirements
Top Departments by AI Mention Rate
Analysis
AI skills are increasingly expected across Dexcom's organization, with 9.8% of all job postings mentioning AI. While tech roles lead at 11.1%, non-tech roles show growing AI requirements at 9.4%, particularly in Finance and Marketing departments, indicating a company-wide AI transformation strategy.
View Sample Job Postings (8 sources)
Key Metrics
AI Initiatives
Smart Food Logging Feature
July 2025
AI-powered photo meal logging for Stelo and G7 CGM systems
Users can take photos of food where AI automatically identifies ingredients and populates meal descriptions. Available across Stelo and G7 platforms
G7 15 Day CGM System
2025
Extended-wear continuous glucose monitor with 15.5-day lifespan
Longest lasting CGM system with 15% longer wear time than standard G7, launched to DME providers and expanding to pharmacies
Dexcom GenAI Platform
December 2024
First generative AI platform in glucose biosensing, integrated into Stelo CGM
Built on Google Cloud's Vertex AI platform and Gemini models, analyzes individual health data patterns to provide actionable insights on diet, exercise, and sleep
Partnership with Oura
November 2024
Strategic partnership integrating Dexcom glucose data with Oura Ring biometrics
Two-way data flow between Dexcom CGMs and Oura Ring, providing comprehensive metabolic health insights combining glucose with vital signs, sleep, stress, and activity data
Stelo Over-the-Counter CGM
March 2024
First over-the-counter continuous glucose monitor cleared by FDA
Designed for adults with type 2 diabetes not using insulin, prediabetics, and wellness-focused consumers
Frequently Asked Questions
Dexcom became the first CGM manufacturer to integrate generative AI into glucose biosensing technology, using Google Cloud's Vertex AI and Gemini models to provide personalized insights on how lifestyle choices impact glucose levels.
Users can take photos of their food in the Stelo or G7 app, where AI automatically identifies ingredients and populates meal descriptions, making food tracking easier and more consistent.
The partnership enables two-way data flow between Dexcom glucose sensors and Oura Ring, combining glucose data with vital signs, sleep, stress, and activity data for comprehensive metabolic health insights.
Stelo is cleared for adults 18 and older with type 2 diabetes who don't take insulin, as well as prediabetics and wellness-focused consumers interested in metabolic health.
Under new CEO Jake Leach, Dexcom plans to introduce additional GenAI-powered features, expand AI capabilities across their product portfolio, and transform from a medical device company to a comprehensive metabolic health platform.
In Application
| Application | Vendor | Use Case |
|---|---|---|
| Google Cloud Vertex AI | Google Cloud | Foundation for building proprietary GenAI platform for glucose biosensing insights |
| Google Gemini Models | Google Cloud | Large language models powering personalized health recommendations in Stelo app |
Sources
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
Dexcom adds generative AI to over-the-counter CGMs
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
Dexcom and ŌURA Announce Strategic Partnership
Dexcom Reports Preliminary, Unaudited Results for Q4 and Fiscal Year 2025
Related Companies
About AI Tracker
AI Tracker is a research project by Larridin, the AI execution intelligence platform.
Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.
Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.